Orbis Medicines ApS

Egen beskrivelse på virk.dk

Orbis Medicines ApS is a private biopharmaceutical company based in Copenhagen, Denmark, with a subsidiary in Lausanne, Switzerland. The Swiss subsidiary is remunerated for intragroup services rendered under an intercompany (cost-plus) service agreement, with a markup on the professional services provided to the Company in Denmark.Orbis Medicines is focused on pioneering a new era for oral macrocycle drug discovery. Macrocycles are a large and diverse family of compounds with highly desirable therapeutic properties, but historically, they have been challenging to develop as oral drugs. Orbis Medicines’ programs focus on high-value oral alternatives to blockbuster biologic drugs and are designed to maximise value for patients. Orbis Medicines has a proprietary technology platform using generative AI for identifying a new class of fully synthetic macrocycle compounds.